Abstract

20 years ago, enzyme catalysis was investigated using theoretical methods with systems as small as 20 atoms and many scientists were, of course, concerned to which extent it even made sense to study biological molecules with such limited approaches. Fortunately, software and hardware have evolved and today we can study complex biological processes with a myriad of computational methods. We believe that the most important thing is to use the right method for each situation.

In this talk, I will show how R&D focused on computational enzyme engineering can be successfully transferred to a business idea.